This study analyzed 225 pediatric heart transplants performed over a decade in Iran. The 1-year, 3-year, and 5-year survival rates were 85.7%, 79.7%, and 73.9%, respectively. Key mortality risk factors included donor age (HR: 1.04, p=0.03), male donor gender (HR: 2.04, p=0.05), and rituximab treatment (HR: 2.44, p=0.05). These findings provide insights for improving pediatric heart transplant outcomes.
Please check your email for instructions on resetting your password.
If you do not receive an email within 10 minutes, your email address may not be registered,
and you may need to create a new Wiley Online Library account.
Request Username
Can't sign in? Forgot your username?
Enter your email address below and we will send you your username
If the address matches an existing account you will receive an email with instructions to retrieve your username